Skip to main content

Table 3 Univariate and Multivariate survival analysis of patients after propensity-score match (N = 1032)

From: The long-term survival outcomes of gastric cancer patients with total intravenous anesthesia or inhalation anesthesia: a single-center retrospective cohort study

Characteristics

Univariate

Multivariate

HR

95% CI

P value

HR

95% CI

P value

Age, years

< 65 vs. ≥65

1.462

1.198–1.785

< 0.001

1.421

1.159–1.743

0.001

Gender

Male vs. Female

0.955

0.774–1.179

0.669

   

Tumor location

AEG vs. Non-AEG

0.783

0.629–0.975

0.029

1.006

0.802–1.261

0.961

Tumor size, cm

< 5 vs. ≥5

2.513

2.052–3.077

< 0.001

1.382

1.100–1.736

0.005

Macroscopic Type

Type 0–2 vs. Type 3–4

1.963

1.615–2.386

< 0.001

1.118

0.903–1.383

0.306

Differentiate Degree

G1–2 vs. G3

1.407

1.077–1.837

0.012

1.12

0.849–1.478

0.422

Radical Degree

R0 vs. R1/R2

2.079

0.985–4.391

0.055

1.367

0.644–2.905

0.416

Lymphadenectomy degree

D1/D1+ vs. D2/D2+

1.220

0.883–1.686

0.229

   

TNM stage

I vs. II

3.440

2.383–4.965

< 0.001

3.214

2.197–4.703

< 0.001

I vs. III

6.691

4.775–9.376

< 0.001

5.569

3.834–8.089

< 0.001

Adjuvant Chemotherapy

No vs. Yes

0.833

0.685–1.013

0.068

0.693

0.567–0.847

< 0.001

Anesthesia method

IVA vs. IHA

0.957

0.779–1.177

0.679

0.946

0.769–1.163

0.597

NSAIDs

No vs. Yes

0.574

0.256–1.285

0.177

   
  1. Abbreviations: HR Hazard ratio, CI Confidence interval, AEG Adenocarcinoma of esophagogastric junction, TIVA Total intravenous anesthesia, IHA Inhalation anesthesia, NSAIDs Nonsteroidal Anti-inflammatory Drugs
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us